| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies. Agenus is also actively involved in vaccine development programs, featuring the Prophage vaccine candidate and QS-21 Stimulon, a widely recognized saponin-based …
Over the last 12 months, insiders at Agenus Inc. have bought $0 and sold $0 worth of Agenus Inc. stock.
On average, over the past 5 years, insiders at Agenus Inc. have bought $343,050 and sold $118,346 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500,000 shares for transaction amount of $324,050 was made by ARMEN GARO H (See Remarks) on 2024‑02‑15.
| 2024-02-15 | ARMEN GARO H | See Remarks | 500,000 0.0915% | $0.65 | $324,050 | -58.14% | ||
| 2023-11-15 | WIINBERG ULF | director | 25,000 0.0067% | $0.76 | $19,000 | -20.64% | ||
| 2022-01-06 | Sale | O'Day Steven J | Chief Medical Officer | 38,679 0.0149% | $3.06 | $118,346 | -16.94% | |
| 2021-09-13 | Sale | ARMEN GARO H | Chairman and CEO | 82,107 0.0357% | $6.50 | $533,696 | -56.93% | |
| 2021-09-10 | Sale | KLASKIN CHRISTINE M | PFO & PAO | 11,120 0.0047% | $6.50 | $72,280 | -57.69% | |
| 2020-06-17 | Sale | INCYTE CORP | 10 percent owner | 283,840 0.1709% | $3.66 | $1.04M | +4.04% | |
| 2020-06-16 | Sale | INCYTE CORP | 10 percent owner | 144,160 0.0877% | $3.66 | $528,015 | +4.63% | |
| 2020-06-15 | Sale | INCYTE CORP | 10 percent owner | 384,025 0.2247% | $3.57 | $1.37M | +3.05% | |
| 2020-06-12 | Sale | INCYTE CORP | 10 percent owner | 9,100 0.0055% | $3.58 | $32,556 | +6.30% | |
| 2020-06-11 | Sale | INCYTE CORP | 10 percent owner | 183,875 0.1139% | $3.77 | $692,786 | +3.20% | |
| 2017-12-12 | Sale | Valentine Karen | Chief Legal Officer | 16,716 0.0174% | $3.46 | $57,842 | -16.91% | |
| 2017-12-12 | Sale | KLASKIN CHRISTINE M | VP, Finance | 11,220 0.0117% | $3.46 | $38,836 | -16.91% | |
| 2017-12-12 | Sale | Baysal Ozer | Chief Commercial Officer | 7,424 0.0077% | $3.46 | $25,691 | -16.91% | |
| 2017-12-12 | Sale | Buell Jennifer | Chief Communications Officer | 7,022 0.0073% | $3.46 | $24,304 | -16.91% | |
| 2017-12-12 | Sale | Duncan Alex | Chief Technology Officer | 13,092 0.0137% | $3.46 | $45,302 | -16.91% | |
| 2017-10-30 | ARMEN GARO H | Chairman & CEO | 80,776 0.0835% | $3.61 | $291,706 | -2.11% | ||
| 2017-10-27 | ARMEN GARO H | Chairman & CEO | 119,224 0.1159% | $3.51 | $418,524 | -5.18% | ||
| 2017-04-12 | ARMEN GARO H | Chairman & CEO | 58,912 0.0604% | $3.29 | $194,109 | +18.52% | ||
| 2017-04-10 | ARMEN GARO H | Chairman & CEO | 141,088 0.1464% | $3.37 | $474,930 | +16.21% | ||
| 2017-02-14 | INCYTE CORP | 10 percent owner | 20M 29.1662% | $6.00 | $120M | -14.32% |
| INCYTE CORP | 10 percent owner | 16972968 37.5825% | $113.21M | 1 | 5 | <0.0001% |
| ARMEN GARO H | See Remarks | 625969 1.3861% | $4.18M | 26 | 6 | +16.59% |
| WIINBERG ULF | director | 124063 0.2747% | $827,500.21 | 2 | 0 | <0.0001% |
| Sharp Shalini | director | 81311 0.18% | $542,344.37 | 2 | 15 | +24.13% |
| HATSOPOULOS JOHN | director | 65000 0.1439% | $433,550.00 | 3 | 0 | +179.69% |
| Baysal Ozer | Chief Commercial Officer | 58790 0.1302% | $392,129.30 | 1 | 1 | +35.69% |
| MARGARET EISEN | director | 20000 0.0443% | $133,400.00 | 2 | 0 | +21.26% |
| Ballantyne Charles Evan | Chief Financial Officer | 10000 0.0221% | $66,700.00 | 1 | 0 | <0.0001% |
| Wright Timothy | director | 10000 0.0221% | $66,700.00 | 1 | 0 | <0.0001% |
| Thornton Peter | CFO & Sr. VP | 5000 0.0111% | $33,350.00 | 1 | 0 | +22.52% |
$64,733,831 | 40 | 5.69% | $299.32M | |
Agenus Inc. (AGEN) | $140,595,157 | 34 | 17.93% | $301.23M |
$109,019,806 | 28 | 7.37% | $263.86M | |
$2,471,510 | 19 | 17.33% | $334.18M | |
$104,171,521 | 16 | 20.21% | $275.53M |
| Increased Positions | 46 | +42.2% | 3M | +33.61% |
| Decreased Positions | 43 | -39.45% | 1M | -16.37% |
| New Positions | 21 | New | 1M | New |
| Sold Out Positions | 12 | Sold Out | 211,439 | Sold Out |
| Total Postitions | 112 | +2.75% | 10M | +17.24% |
| Vanguard Group Inc | $8,300.00 | 7.56% | 2.57M | +36,983 | +1.46% | 2025-09-30 |
| Siren, L.L.C. | $3,438.00 | 3.13% | 1.06M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $1,774.00 | 1.62% | 549,126 | -228,879 | -29.42% | 2025-09-30 |
| Blackrock, Inc. | $1,767.00 | 1.61% | 547,112 | +43,024 | +8.54% | 2025-09-30 |
| Bank Of America Corp /De/ | $1,193.00 | 1.09% | 369,314 | -51,364 | -12.21% | 2025-09-30 |
| Millennium Management Llc | $1,126.00 | 1.03% | 348,754 | -155,755 | -30.87% | 2025-09-30 |
| Geode Capital Management, Llc | $1,121.00 | 1.02% | 346,991 | +29,582 | +9.32% | 2025-09-30 |
| Walleye Capital Llc | $1,004.00 | 0.91% | 310,788 | +112,500 | +56.74% | 2025-09-30 |
| Acadian Asset Management Llc | $662.00 | 0.6% | 205,091 | +205,091 | New | 2025-09-30 |
| Susquehanna International Group, Llp | $617.00 | 0.56% | 190,954 | -11,179 | -5.53% | 2025-09-30 |